CN105687480A - Immunoregulatory traditional Chinese medicine composition and preparation - Google Patents
Immunoregulatory traditional Chinese medicine composition and preparation Download PDFInfo
- Publication number
- CN105687480A CN105687480A CN201610121170.4A CN201610121170A CN105687480A CN 105687480 A CN105687480 A CN 105687480A CN 201610121170 A CN201610121170 A CN 201610121170A CN 105687480 A CN105687480 A CN 105687480A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- immunoregulatory
- medicine composition
- tremella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000004957 immunoregulator effect Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241001506047 Tremella Species 0.000 claims abstract description 26
- 241000222336 Ganoderma Species 0.000 claims abstract description 24
- 241000756943 Codonopsis Species 0.000 claims abstract description 21
- 244000268590 Euryale ferox Species 0.000 claims abstract description 20
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 19
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 19
- 235000001715 Lentinula edodes Nutrition 0.000 claims abstract description 19
- 239000004615 ingredient Substances 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims description 38
- 239000007788 liquid Substances 0.000 claims description 21
- 240000000588 Hericium erinaceus Species 0.000 claims description 20
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 20
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 19
- 244000309464 bull Species 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 10
- -1 electuary Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 210000000952 spleen Anatomy 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 150000004676 glycans Chemical class 0.000 abstract description 14
- 229920001282 polysaccharide Polymers 0.000 abstract description 14
- 239000005017 polysaccharide Substances 0.000 abstract description 14
- 230000036737 immune function Effects 0.000 abstract description 8
- 230000002519 immonomodulatory effect Effects 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 241001061264 Astragalus Species 0.000 abstract description 2
- 235000006533 astragalus Nutrition 0.000 abstract description 2
- 229930003935 flavonoid Natural products 0.000 abstract description 2
- 150000002215 flavonoids Chemical class 0.000 abstract description 2
- 235000017173 flavonoids Nutrition 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000282693 Cercopithecidae Species 0.000 abstract 1
- 208000035240 Disease Resistance Diseases 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 21
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 20
- 241000699670 Mus sp. Species 0.000 description 18
- 230000036039 immunity Effects 0.000 description 16
- 210000002540 macrophage Anatomy 0.000 description 11
- 229960000890 hydrocortisone Drugs 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 230000000242 pagocytic effect Effects 0.000 description 8
- 206010057249 Phagocytosis Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 230000008782 phagocytosis Effects 0.000 description 7
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 208000033065 inborn errors of immunity Diseases 0.000 description 6
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 229940088592 immunologic factor Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 102000000588 Interleukin-2 Human genes 0.000 description 3
- 108010002350 Interleukin-2 Proteins 0.000 description 3
- 229920001491 Lentinan Polymers 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 229940115286 lentinan Drugs 0.000 description 3
- 229960001614 levamisole Drugs 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 241000221198 Basidiomycota Species 0.000 description 2
- 241000167880 Hirundinidae Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000222341 Polyporaceae Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 235000021551 crystal sugar Nutrition 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- MUMCCPUVOAUBAN-UHFFFAOYSA-N liriodenine Chemical compound C1=NC(C(=O)C=2C3=CC=CC=2)=C2C3=C(OCO3)C3=CC2=C1 MUMCCPUVOAUBAN-UHFFFAOYSA-N 0.000 description 2
- FVRABHGHBLRNNR-UHFFFAOYSA-N liriodenine Natural products O=C1C=CC=c2c1cc3nccc4cc5OCOc5c2c34 FVRABHGHBLRNNR-UHFFFAOYSA-N 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 101710186708 Agglutinin Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- XCUCMLUTCAKSOZ-FIRIVFDPSA-N Liensinine Chemical compound C([C@@H]1C=2C=C(C(=CC=2CCN1C)OC)OC=1C(O)=CC=C(C=1)C[C@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 XCUCMLUTCAKSOZ-FIRIVFDPSA-N 0.000 description 1
- XCUCMLUTCAKSOZ-JSOSNVBQSA-N Liensinine Natural products C([C@@H]1C=2C=C(C(=CC=2CCN1C)OC)OC=1C(O)=CC=C(C=1)C[C@@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 XCUCMLUTCAKSOZ-JSOSNVBQSA-N 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001492261 Pleurotaceae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an immunoregulatory traditional Chinese medicine composition and a preparation. According to the formulation, the immunoregulatory traditional Chinese medicine composition is prepared from, by weight, 40-60 parts of ganoderma, 40-60 parts of monkey head mushrooms, 40-60 parts of tremella, 30-50 parts of lentinus edodes, 30-50 parts of poria cocos, 10-30 parts of milkvetch roots, 10-30 parts of lotus seeds, 20-40 parts of fructus lycii, 10-30 parts of radix codonopsis and 10-30 parts of gorgon fruits. Main effective ingredients of Chinese herbal medicine under compatibility include biotic polysaccharide, protein, flavonoid and the like, the functional ingredients are in scientific compatibility, and the immunomodulatory effect is good. Besides, the immunoregulatory traditional Chinese medicine composition aims at performing regulation, supporting the healthy energy, invigorating the spleen and stomach, supplementing both qi and blood and the like, and can enhance the immunologic function and disease resistance of an organism.
Description
Technical field
The present invention relates to the field of Chinese medicines, particularly a kind of immunoregulatory Chinese medicine composition。
Background technology
Immunity is the meaning of " release pestilence " the earliest, refers to the health resistance again infecting generation to infectious agent, and the power of resistance can be expressed by immunity。So-called infectious agent refers to the pathogenic microorganism such as antibacterial, virus, and this just makes immunity and microbiology closely related, makes to it is believed that immunity only refers to the health defense function to infecting, and health is all advantageous for by immunity。Along with going deep into of research, immunity be there has also been new understanding, the early stage concept thinking above-mentioned can not definitely reflect the essence of immunity because it is found that the anaphylaxis unrelated with infectious disease, organ-graft refection, tumor develop, sterile, old and feeble etc. actually all relevant with immunity。So the Concept of Immunity in modern times should refer to health identification " self " and the activity of " dissident ", it it is exactly a kind of activity distinguishing " enemy ", " I ", " dissident " (enemy) can be the organ in he human blood, the transplant that the blood group that the microorganism in intrusive body, blood transfusion accidentally enter is not inconsistent, be different from the tumor cell etc. of body normal components, this all of " foreign body " that body can be stimulated to produce immunne response, is referred to as " antigen "。The immune function of body, is first to discriminate between self and dissident's composition, then passes through immunologic process, is eventually exhibited as the repulsion to dissident's composition (antigen), and the consequence that this repulsion causes is many favourable to body, such as opposing infection etc.;But body is then harmful to by some, as there is anaphylaxis, autoimmune disease etc., so it is considered that it is incomplete that body is all advantageous for concept by immunity。
Current people use the method regulating immunity a lot, but respectively have superiority and be respectively arranged with deficiency, so research and development have its huge social value and economic worth with China's Chinese material medicine resource advantage and product that motherland's theory of medicine advantage is background, no side effects, super quality and competitive price。
Summary of the invention
For solving the problems referred to above, it is an object of the invention to provide immunoregulatory Chinese medicine composition, it has adjustment immunologic function, no side effects, super quality and competitive price。
The object of the present invention is achieved like this: a kind of immunoregulatory Chinese medicine composition, it is characterized in that: calculate by weight, its formula is composed of the following components: Ganoderma 40~60 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 40~60 parts, 40~60 parts of Tremella, 30~50 parts of Lentinus Edodes, 30~50 parts of Poria, the Radix Astragali 10~30 parts, 10~30 parts of Semen Nelumbinis, Fructus Lycii 20~40 parts, Radix Codonopsis 10~30 parts, Semen Euryales 10~30 parts。
Preferably, calculating by weight, its formula is composed of the following components: Ganoderma 45~55 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 45~55 parts, 45~55 parts of Tremella, 35~45 parts of Lentinus Edodes, 35~45 parts of Poria, the Radix Astragali 15~25 parts, 15~25 parts of Semen Nelumbinis, Fructus Lycii 25~35 parts, Radix Codonopsis 15~25 parts, Semen Euryales 15~25 parts。
Optimum, calculating by weight, its formula is composed of the following components: Ganoderma 50 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 50 parts, 50 parts of Tremella, 45 parts of Lentinus Edodes, 40 parts of Poria, the Radix Astragali 15 parts, 20 parts of Semen Nelumbinis, Radix Codonopsis 10 parts, Fructus Lycii 20 parts, Semen Euryales 20 parts。
A kind of immunoregulatory Chinese medicine preparation, including effective ingredient, this effective ingredient is the extract of above-mentioned immunoregulatory Chinese medicine composition。
The dosage form of described Chinese medicine preparation is oral liquid, electuary, capsule or tablet。
The extract of described Chinese medicine composition is water extract。
The Chinese herbal medicine principle active component of compatibility of the present invention is biological polyoses, protein, flavonoid etc., functional component proportioning science, immunoregulation effect effect is good, additionally, currently invention addresses adjustment, strengthening the body resistance, spleen reinforcing stomach invigorating, qi and blood tonifying etc. can the immunologic function of enhancing body and resistances against diseases。
Detailed description of the invention
The present invention is a kind of immunoregulatory Chinese medicine composition, calculating by weight, its formula is composed of the following components: Ganoderma 40~60 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 40~60 parts, 40~60 parts of Tremella, 30~50 parts of Lentinus Edodes, 30~50 parts of Poria, the Radix Astragali 10~30 parts, 10~30 parts of Semen Nelumbinis, Fructus Lycii 20~40 parts, Radix Codonopsis 10~30 parts, Semen Euryales 10~30 parts。
Preferably, calculating by weight, its formula is composed of the following components: Ganoderma 45~55 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 45~55 parts, 45~55 parts of Tremella, 35~45 parts of Lentinus Edodes, 35~45 parts of Poria, the Radix Astragali 15~25 parts, 15~25 parts of Semen Nelumbinis, Fructus Lycii 25~35 parts, Radix Codonopsis 15~25 parts, Semen Euryales 15~25 parts。
Optimum, calculating by weight, its formula is composed of the following components: Ganoderma 50 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 50 parts, 50 parts of Tremella, 45 parts of Lentinus Edodes, 40 parts of Poria, the Radix Astragali 15 parts, 20 parts of Semen Nelumbinis, Fructus Lycii 20 parts, Radix Codonopsis 10 parts, Semen Euryales 20 parts。
In the medicinal raw material that the present invention adopts, Ganoderma: Ganoderma is the basidiomycetes of Polyporaceae, it begins to be loaded in the Shennong's Herbal of Han dynasty as medicine, and successive dynasties medical book is classified as top grade。Ganoderma has the effect such as invigorating the spleen and replenishing QI, relieving cough and asthma, for diseases such as malaise, insomnia cardiopalmus, cough and asthma due to lung deficiency, asthenia is losed heart, anorexias。Ganoderma is a kind of Chinese crude drug that " Chinese Pharmacopoeia " includes, and is also a kind of fungus of dietotherapeutic。Ganoderma is containing ganoderan, triterpenoid compound etc.;Modern pharmacological research shows, Ganoderma has many-sided biological activity, including antitumor, protect the liver, immunomodulating, to central nervous system, immune system, cardiovascular system, blood sugar lowering, blood fat reducing, defying age, antioxidation, raising body's hypoxia tolerance and resisting fatigue, additionally it is possible to anti-inflammation, relieving cough and asthma, eliminate the phlegm and treat chronic tracheitis etc.。
Tremella: Tremella Tremellaceae, Tremella fungus, is famous and precious nutritious tonifying good merchantable brand, is again the strong tonic of righting, and its tremella polysaccharide has the pharmacological actions such as immunostimulant, defying age, antitumor, mutation, hepatoprotective and reducing blood sugar and blood fat;Regulate immunology tremella polysaccharide and tremella polysaccharide spore can activate Turnover of Mouse Peritoneal Macrophages, increase its phagocytic activity;Humoral immunization。Tremella polysaccharide can promote that the hemolysin of normal mouse and the suppressed mice of immunologic function is formed;Impact on cellular immunization。Tremella polysaccharide has the LT effect of certain promotion, makes T lymphocyte and bone-marrow-derived lymphocyte all have increase;Also there is the effect of agglutinin, can the red thin race of coagulation, participate in the effect such as cytophagous activation and biophylaxis, improve nonspecific immunity function。
Lentinus Edodes: Lentinus Edodes is the basidiomycetes of Pleurotaceae, famous and precious edible one of the medicinal fungus of holding concurrently in the world, it contains multiple effective Pharmaceutical ingredients, and the lentinan that especially it contains is to have antiviral, antitumor, adjustment immunologic function and stimulate the functions such as interferon formation;The pharmacological action of lentinan is it is not direct aggression etiology, but by immune stimulatory cell maturation, differentiation and propagation, improves host body balance, reaches to recover and improve the host cell reactivity to lymphokine, hormone and other physiologically active factor。Therefore it is often biological response modifier by person。
Poria: Poria is On Polyporaceae, for one of Chinese medicine eight delicacies, nature and flavor are sweet, light, flat;GUIXIN, lung, spleen, kidney channel;There is the effects such as promoting diuresis to eliminate damp pathogen, spleen invigorating invigorating middle warmer, tranquilizing by nourishing the heart。Have loose bowels for edema oliguria, phlegm retention vertigo and palpitation, insufficiency of the spleen lack of appetite, loose stool, irritability, the disease such as palpitation with fear insomnia。Poria main component has pachyman, fuling triterpene etc., modern pharmacology research show Poria there is immunomodulating, antitumor, protect the liver, antioxidation, antiinflammatory, antiviral, the multiple pharmacological effect such as diuresis。
Fructus Lycii: Fructus Lycii is plant of Solanaceae, its sweet in the mouth, property is put down。Return Liver Channel, kidney channel, lung meridian。Function: nourishing the liver, nourishing kidney, lung moistening。Cure mainly: caused by liver and kidney deficiency;Have a dizzy spell;Visually unclear;Soreness of the waist and knees;Impotence and seminal emission;Cough due to consumptive disease;Quench one's thirst taking fluids profusely, be famous and precious medical material and tonic。Modern study finds that Fructus Lycii main nutrient composition has lycium barbarum polysaccharide, essence fiber, glycine betaine, aminoacid etc.;There is promotion immunity, antioxidation, slow down aging, reduction blood glucose, promote the effects such as apoptosis of tumor cells, Antiradiation injury, blood fat reducing。
Hericium erinaceus (Bull. Ex Fr.) Pers.: be famous medicine-food two-purpose fungus。Hericium erinaceus (Bull. Ex Fr.) Pers. property is put down, sweet in the mouth, and favourable the five internal organs are aid digestion, and the effect such as nourish the body, and particularly to gastric ulcer, the patient such as duodenal ulcer and neurasthenia has good health-care effect。Hericium Erinaceus Polysaccharide is one of its main active, has the effects such as immunomodulating, antitumor, defying age, blood sugar lowering, blood fat reducing, mutation, radioprotective。
The Radix Astragali: the Radix Astragali is leguminous plant, has effect of tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, expelling pus and toxin by strengthening QI, inducing diuresis to remove edema, expelling pus and promoting granulation。Modern pharmacological research shows, the Radix Astragali has enhancing human body immunity function, and heart tonifying blood pressure lowering, blood sugar lowering, diuresis, defying age, resisting fatigue, antitumor, antiviral, calmness, analgesia etc. act on。
Semen Nelumbinis: Semen Nelumbinis are the nutrient healths that China is traditional, sweet-puckery flavor, property are flat。Recording according to Compendium of Materia Medica, Semen Nelumbinis are laid one's heart bear effect of kidney, thick the intestines and stomach, controlling nocturnal emission with astringent drugs gas, tonifying deficiency, profit knowledge, tool nourishing the heart and kidney, invigorating the spleen to arrest diarrhea。Semen Nelumbinis contain the trace element such as starch, polysaccharide, protein, fat and calcium, phosphorus, ferrum, zinc, possibly together with alkaloids such as nuciferine, oxoushinsunine, liensinines。Oxoushinsunine, has the effect suppressing nasopharyngeal carcinoma, and liensinine has hypotensive effect。
Semen Euryales: begin to be loaded in Shennong's Herbal, it is classified as top grade, have another name called Caput Gallus domesticus, go through version " Chinese Pharmacopoeia " all on the books, for the dry mature kernal of nymphaeaceae plant Gorgon euryale, there is effect of supplementing the kidney to control the nocturnal, tonifying spleen and stopping diarrhea, damp eliminating leukorrhagia stopping, cure mainly nocturnal emission, spermatorrhea, the enuresis, frequent micturition, insufficiency of the spleen chronic diarrhea, nebulousurine, leukorrhagia。Have " in water Radix Ginseng " and the good reputation of " in water Arillus Longan ", be traditional Chinese crude drug and precious natural tonic。Modern study shows flavone and cyclic peptide, glucityl sterol compound etc.;There is antioxidation, regulate the effect of immunity。
Radix Codonopsis: be Campanulaceae, its sweet in the mouth, property is put down, and enters spleen, lung two warp, has invigorating the spleen and replenishing QI, the merit of the stomach function regulating that promotes the production of body fluid。Containing polysaccharide and the several amino acids constituting nutrient substance, multiple inorganic elements;Promoting blood and immunization of cell, Radix Codonopsis can improve the body resistivity to destructive stimulus, and Radix Codonopsis extract can strengthen the ability of peritoneal macrophage phagocytosis chicken red blood cell。
The present invention with Ganoderma, Hericium erinaceus (Bull. Ex Fr.) Pers. for monarch drug, stomach function regulating spleen invigorating, strengthening the body resistance, and the combination of ganoderan, Hericium Erinaceus Polysaccharide can significantly improve the vigor of macrophage, strengthens its phagocytic activity;With Tremella, Poria, Lentinus Edodes, the Radix Astragali, Semen Nelumbinis for ministerial drug, spleen invigorating eliminating dampness by diuresis, QI invigorating, and pachyman, tremella polysaccharide, lentinan, astragalus polysaccharides, Semen Nelumbinis polysaccharide etc. combine and can significantly improve a large amount of propagation that can promote immunocyte, cytokine such as interleukin 1, interleukin II, tumor necrosis factor is made to secrete in a large number;With Fructus Lycii, Radix Codonopsis, Semen Euryales for adjuvant drug QI invigorating YIN nourishing, and the combination of lycium barbarum polysaccharide, Radix Codonopsis polysaccharide, Semen Euryales flavone can significantly improve the raising body resistivity to destructive stimulus。All medicines share can regulate, strengthening the body resistance, spleen reinforcing stomach invigorating, qi and blood tonifying etc. can the immunologic function of enhancing body and resistances against diseases。
After medicine of the present invention configures according to component, can take directly as decoction decocting, corresponding dosage form can also be prepared into by the common process of pharmacy of Chinese materia medica, such as oral liquid, electuary, capsule or tablet etc., including effective ingredient, this effective ingredient is the extract of above-mentioned immunoregulatory Chinese medicine composition。Preferably, this extract is the water extract obtained by conventional decocting (being such as commonly performed twice water to carry)。Pharmaceutic adjuvant can be added as required。
Below in conjunction with object lesson, the present invention is further explained, but the present invention is not limited to this specific examples。
Embodiment 1
Formula: Ganoderma 50 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 50 parts, 50 parts of Tremella, 45 parts of Lentinus Edodes, 40 parts of Poria, the Radix Astragali 15 parts, 20 parts of Semen Nelumbinis, Fructus Lycii 20 parts, Radix Codonopsis 10 parts, Semen Euryales 20 parts。
Take ten tastes such as Ganoderma and add 12 times amount water;Infiltrate 1 hour;Decoct 2 hours;Filter;The another device of filtrate preserves;Filtering residue adds 10 times amount water;Decoct 2 hours;Filter;Collecting decoction;Being evaporated to relative density is 1.05;Cold preservation 48 hours;Take cold preservation liquid to be centrifuged;Boiling 10 minutes, cooling, titanium rod filters;Add water to quantitatively;Subpackage sterilizing, thus obtaining the product oral liquid。For mouthfeel more preferably, appropriate crystal sugar can be added in oral liquid。Consider diabetes patient colony, it is also possible to without crystal sugar。The present embodiment oral liquid (1ml is containing medical material 0.5g), crowd recommends daily intaking amount to be 30ml/60kgBW (i.e. 0.5ml/kgBW)。
Embodiment 2
Formula: Ganoderma 40 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 40 parts, 40 parts of Tremella, 30 parts of Lentinus Edodes, 30 parts of Poria, the Radix Astragali 10 parts, 10 parts of Semen Nelumbinis, Fructus Lycii 20 parts, Radix Codonopsis 10 parts, Semen Euryales 10 parts。
Preparation method is with embodiment 1。
Embodiment 3
Formula: Ganoderma 60 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 60 parts, 60 parts of Tremella, 50 parts of Lentinus Edodes, 50 parts of Poria, the Radix Astragali 30 parts, 30 parts of Semen Nelumbinis, Fructus Lycii 40 parts, Radix Codonopsis 30 parts, Semen Euryales 30 parts。
Preparation method is with embodiment 1。
Embodiment 4
Formula: Ganoderma 45 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 50 parts, 45 parts of Tremella, 35 parts of Lentinus Edodes, 40 parts of Poria, the Radix Astragali 20 parts, 15 parts of Semen Nelumbinis, Fructus Lycii 15 parts, Radix Codonopsis 15 parts, Semen Euryales 15 parts。
Preparation method is with embodiment 1。
Embodiment 5
Formula: Ganoderma 55 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 55 parts, 55 parts of Tremella, 45 parts of Lentinus Edodes, 45 parts of Poria, the Radix Astragali 25 parts, 25 parts of Semen Nelumbinis, Fructus Lycii 35 parts, Radix Codonopsis 25 parts, Semen Euryales 25 parts。
Preparation method is with embodiment 1。
Embodiment 6
Formula: Ganoderma 50 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 50 parts, 45 parts of Tremella, 30 parts of Lentinus Edodes, 50 parts of Poria, the Radix Astragali 25 parts, 15 parts of Semen Nelumbinis, Fructus Lycii 35 parts, Radix Codonopsis 15 parts, Semen Euryales 25 parts。
Preparation method is with embodiment 1。
Test example
Illustrate that medicine of the present invention strengthens the effect of immunologic function by animal experiment report。With the mice of immunologic hypofunction caused by hydrocortisone for animal subject model, using levamisole as positive control。
1. sample source and process
By each for the embodiment of the present invention 1 medical material according to proved recipe ratio compatibility, routine prepares water decoction, changes mice dosage into by adult's clinical application amount, and adjusting concentration is that large and small 2 dosage (being respectively equivalent to crude drug 1g/ml, 0.25g/ml) are standby。
2 animals
Kunming mice 50, male and female half and half, weight 18~22g, it is randomly divided into that Normal group, model group, levamisole positive controls and invention oral liquid be low, high dose group, often group 10。Normal group and model group gavage normal saline, 0.5mL/d, continuous 10d;Levamisole group gavage levamisole, 5mg/kg, continuous 10d;Invention oral liquid is low, the conventional water decoction of preparing of high dose group, 0.5mL/d, continuous 10d。Each group mice 4-7d subcutaneous injection hydrocortisone, 50mg/d, continuous 4d except Normal group。
3. macrophage phagocytosis of mice test
Each group mice last is administered next day, takes out peritoneal exudate cells after every lumbar injection 5% chicken red blood cells 1mL, 2h, the fixing dyeing of acetone-methanol (1: 1), measures macrophage phagocytic percentage rate and phagocytic index。
Phagocytic percentage=100 macrophage swallows macrophage number/100 macrophage × 100% of chicken red blood cell;Phagocytic index=100 macrophage swallows chicken red blood cell number/100 macrophage。
4. Oral Liquid On Mice immune organ of the present invention impact test
Next day is put to death animal in each group mice last administration, wins thymus and spleen, weighs quality, calculates Thymus and Spleen index。Thymus index or index and spleen index=Organ weight/weight × 100%。
5. the impact of mouse immune organ and immune factor is tested each group of mice last and is administered next day, plucks eyeball and takes blood, separate serum, surveys the content of IL-2, TNF-α, IFN-γ by test kit description method。
6. statistical procedures experimental data all adopts SPSS13.0 software to carry out statistical analysis, and between different groups, indicator difference adopts one factor analysis of variance。
7. result
Hydrocortisone is caused the impact of hypoimmunity mice Peritoneal Macrophage Phagocytosis and compares with Normal group by 7.1 oral liquids of the present invention, model group the phagocytosis ratio and phagocytosis index of macrophage significantly reduces (P < 0.05), it was shown that animal model modeling success;Comparing with model group, oral liquid of the present invention is low, high dose group mouse macrophage phagocytic rate and phagocytic index significantly raise (P < 0.05), it was shown that oral liquid of the present invention can improve macrophage phagocytosis of mice。In Table 1。
Table 1 oral liquid of the present invention hydrocortisone is caused hypoimmunity mice Peritoneal Macrophage Phagocytosis impact (N=10)
Note: * P < 0.05
Hydrocortisone is caused the impact of hypoimmunity mice Immune Organs Index and compares with Normal group by 7.2 oral liquids of the present invention, model group Thymus and Spleen index significantly reduces (P < 0.05), it was shown that the model modeling success of hydrocortisone induced mice immunologic hypofunction;Comparing with model group, oral liquid high dose group Thymus and Spleen index of the present invention significantly raises (P < 0.05), it was shown that oral liquid of the present invention has the effect improving immune organ function。In Table 2。
Table 2 oral liquid of the present invention hydrocortisone is caused hypoimmunity mice Immune Organs Index impact (N=10)
Note: * P < 0.05
Hydrocortisone is caused the impact of hypoimmunity mice immune factor by 7.3 oral liquids of the present invention
Comparing with model group, oral liquid high dose low, of the present invention all can promote that T cell is secreted, and makes the immune factors such as IL-2 in immunologic hypofunction mice serum caused by hydrocortisone, TNF-α and TNF-γ significantly raise (P < 0.05)。In Table 3。
Table 3 oral liquid of the present invention hydrocortisone is caused immune factor content in hypoimmunity mice serum impact (N=10)
Note: * P < 0.05
Clinical trial proves, various subhealth states and the disease because of immunity caused by abnormal is respectively provided with effect of well taking good care of by the medicine of the present invention。It addition, the raw material of the medicine of the present invention is the plant of integration of edible and medicinal herbs, no side effects, it it is a kind of well health promoting product simultaneously。
Claims (6)
1. an immunoregulatory Chinese medicine composition, it is characterized in that: calculate by weight, its formula is composed of the following components: Ganoderma 40~60 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 40~60 parts, 40~60 parts of Tremella, 30~50 parts of Lentinus Edodes, 30~50 parts of Poria, the Radix Astragali 10~30 parts, 10~30 parts of Semen Nelumbinis, Fructus Lycii 20~40 parts, Radix Codonopsis 10~30 parts, Semen Euryales 10~30 parts。
2. immunoregulatory Chinese medicine composition according to claim 1, it is characterized in that: calculate by weight, its formula is composed of the following components: Ganoderma 45~55 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 45~55 parts, 45~55 parts of Tremella, 35~45 parts of Lentinus Edodes, 35~45 parts of Poria, the Radix Astragali 15~25 parts, 15~25 parts of Semen Nelumbinis, Fructus Lycii 25~35 parts, Radix Codonopsis 15~25 parts, Semen Euryales 15~25 parts。
3. immunoregulatory Chinese medicine composition according to claim 1, it is characterized in that: calculate by weight, its formula is composed of the following components: Ganoderma 50 parts, Hericium erinaceus (Bull. Ex Fr.) Pers. 50 parts, 50 parts of Tremella, 45 parts of Lentinus Edodes, 40 parts of Poria, the Radix Astragali 15 parts, 20 parts of Semen Nelumbinis, Radix Codonopsis 10 parts, Fructus Lycii 20 parts, Semen Euryales 20 parts。
4. an immunoregulatory Chinese medicine preparation, including effective ingredient, this effective ingredient is the extract of immunoregulatory Chinese medicine composition described in claim 1,2 or 3。
5. immunoregulatory Chinese medicine preparation according to claim 4, it is characterised in that: the dosage form of described Chinese medicine preparation is oral liquid, electuary, capsule or tablet。
6. immunoregulatory Chinese medicine preparation according to claim 4, it is characterised in that: the extract of described Chinese medicine composition is water extract。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610121170.4A CN105687480A (en) | 2016-03-03 | 2016-03-03 | Immunoregulatory traditional Chinese medicine composition and preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610121170.4A CN105687480A (en) | 2016-03-03 | 2016-03-03 | Immunoregulatory traditional Chinese medicine composition and preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105687480A true CN105687480A (en) | 2016-06-22 |
Family
ID=56223721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610121170.4A Pending CN105687480A (en) | 2016-03-03 | 2016-03-03 | Immunoregulatory traditional Chinese medicine composition and preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105687480A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109078112A (en) * | 2018-10-09 | 2018-12-25 | 河南知鑫生物科技有限公司 | Improve tumour, inflammation class disease formula and preparation method thereof |
CN110115356A (en) * | 2019-06-06 | 2019-08-13 | 广州市美澳健生物科技有限公司 | A kind of strengthen immunity and protection gastric mucosa composition and application method |
CN115153016A (en) * | 2021-04-06 | 2022-10-11 | 大连鑫玉龙海洋生物种业科技股份有限公司 | Sea cucumber polypeptide chelated zinc oral liquid and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101491334A (en) * | 2009-02-19 | 2009-07-29 | 南方李锦记有限公司 | Health food with immunity reinforcement function |
CN102048154A (en) * | 2009-11-10 | 2011-05-11 | 天津市百奥生物技术有限公司 | Health protection food having function of regulating blood sugar and preparation method thereof |
CN104887953A (en) * | 2015-05-14 | 2015-09-09 | 邓学峰 | Oral anti-aging paste formula |
-
2016
- 2016-03-03 CN CN201610121170.4A patent/CN105687480A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101491334A (en) * | 2009-02-19 | 2009-07-29 | 南方李锦记有限公司 | Health food with immunity reinforcement function |
CN102048154A (en) * | 2009-11-10 | 2011-05-11 | 天津市百奥生物技术有限公司 | Health protection food having function of regulating blood sugar and preparation method thereof |
CN104887953A (en) * | 2015-05-14 | 2015-09-09 | 邓学峰 | Oral anti-aging paste formula |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109078112A (en) * | 2018-10-09 | 2018-12-25 | 河南知鑫生物科技有限公司 | Improve tumour, inflammation class disease formula and preparation method thereof |
CN110115356A (en) * | 2019-06-06 | 2019-08-13 | 广州市美澳健生物科技有限公司 | A kind of strengthen immunity and protection gastric mucosa composition and application method |
CN115153016A (en) * | 2021-04-06 | 2022-10-11 | 大连鑫玉龙海洋生物种业科技股份有限公司 | Sea cucumber polypeptide chelated zinc oral liquid and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1762236B (en) | Health-caring product capable of increasing human immunity and its preparation method | |
CN102172269B (en) | Hidegelatin fabricated food with beautification function | |
CN103689563A (en) | Health-preserving health food formula beneficial for improving sleep and preparation method thereof | |
CN102784162A (en) | Edible fungi compound polysaccharides health care treatment preparation | |
CN102161962A (en) | Deer antler blood wine and production process thereof | |
CN103735662A (en) | Pharmaceutical composition of ginseng and donkey-hide gelatin as well as preparation method and use thereof | |
CN102228252A (en) | Application of Chinese medicinal composition in preparation of healthcare foods and medicines for improving hypoxia tolerance | |
CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
CN103156122A (en) | Health-care Astragalus mongholicus porridge and preparation method thereof | |
CN103155985B (en) | Rhizoma polygonati nutrition powder and preparation method thereof | |
CN106177053A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae | |
CN105687480A (en) | Immunoregulatory traditional Chinese medicine composition and preparation | |
CN101032599B (en) | Healthy solution for conditioning skin and losing weight | |
CN103816278B (en) | Composition for reducing blood sugar and application thereof | |
CN102526456A (en) | Health-care medicine formula capable of enhancing immunity and promoting sleep function | |
CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
CN104738626B (en) | A kind of Halth-care composition, its preparation method and application with strengthen immunity effect | |
CN103463177A (en) | Traditional Chinese medicine health care product for improving and enhancing organism immunity | |
CN105994867A (en) | Chocolate with effect of improving immunity and preparation method thereof | |
CN107125751B (en) | Tortoise powder, preparation method and application thereof | |
CN104957515A (en) | Steamed buns assisting to lower blood sugar and preparation method thereof | |
CN114748603A (en) | Medicine-food homologous composition for preventing and treating new coronavirus pneumonia variation or compound yang and application | |
CN1528182A (en) | Health-care food and preparing method thereof | |
CN105796819A (en) | Immunomodulating selenium-rich Chinese herbal medicine composition containing compound polysaccharide and preparation | |
CN100584363C (en) | Traditional Chinese medicine oral liquid for treating damnification of immunity function after chemotherapy of cancer of the esophagus cancer patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160622 |
|
RJ01 | Rejection of invention patent application after publication |